| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 74 Employees | - Last Dividend | 19 Mar 2018 Last Split | - IPO Date |
GenoFocus, Inc. is a company dedicated to the research, development, production, and sales of enzymes and fermentation products, serving customers both in South Korea and internationally. The company, which was founded in the year 2000 and is headquartered in Daejeon, South Korea, has carved a niche for itself in the biotechnology industry by focusing on the creation of specialized enzymes and bioproducts. GenoFocus's operations encompass a broad spectrum, from the advanced research and development of enzyme technologies to the importing and exporting of their novel products. This multifaceted approach positions GenoFocus as a significant player in the global market for industrial enzymes and health care ingredients.
Includes a variety of enzymes developed for specific industrial applications. Notably, lactase, which is marketed for its ability to prevent pathogen infection/proliferation and food poisoning, alongside addressing allergies and atopy. Another significant product is Proteinase K, a recombinant protease from the fungal strain Tritirachium album, widely used in the biotech industry for isolating DNA from cells and tissues, removing DNase and RNase for pure DNA and RNA extraction, and enhancing PCR cloning efficiency. Catalase, known for its role in decomposing hydrogen peroxide, is utilized across several industries, including semiconductor water treatment, textile processing, and HPPO (hydrogen peroxide to propylene oxide) manufacturing processes.
GenoFocus has developed and offers bio-healthcare ingredients, such as N-phytosphingosine, which is used as a cosmetic material to aid in skin barrier function improvement. Additionally, Vitamin K2 is offered for its benefits to bone and cardiovascular health, reflecting the company's expansion into health and wellness products.
GenoFocus is also involved in the development of superoxide dismutase, an antioxidant enzyme that is currently in preclinical trial. This product highlights GenoFocus, Inc.'s commitment to advancing healthcare solutions through innovative biotechnology research.